Literature DB >> 19268634

Central sympathetic overactivity: maladies and mechanisms.

James P Fisher1, Colin N Young, Paul J Fadel.   

Abstract

There is growing evidence to suggest that many disease states are accompanied by chronic elevations in sympathetic nerve activity. The present review will specifically focus on central sympathetic overactivity and highlight three main areas of interest: 1) the pathological consequences of excessive sympathetic nerve activity; 2) the potential role of centrally derived nitric oxide in the genesis of neural dysregulation in disease; and 3) the promise of several novel therapeutic strategies targeting central sympathetic overactivity. The findings from both animal and human studies will be discussed and integrated in an attempt to provide a concise update on current work and ideas in these important areas.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19268634      PMCID: PMC2679852          DOI: 10.1016/j.autneu.2009.02.003

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  184 in total

1.  Persistent sympathetic activation during chronic antihypertensive therapy: a potential mechanism for long term morbidity?

Authors:  Qi Fu; Rong Zhang; Sarah Witkowski; Armin Arbab-Zadeh; Anand Prasad; Kazunobu Okazaki; Benjamin D Levine
Journal:  Hypertension       Date:  2005-02-28       Impact factor: 10.190

2.  Sympathetic activation restrains endothelium-mediated muscle vasodilatation in heart failure patients.

Authors:  Amilton C Santos; Maria J N N Alves; Maria U P B Rondon; Antonio C P Barretto; Holly R Middlekauff; Carlos E Negrão
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-03-18       Impact factor: 4.733

3.  Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death.

Authors:  D Fischer; S Rossa; U Landmesser; S Spiekermann; N Engberding; B Hornig; H Drexler
Journal:  Eur Heart J       Date:  2004-11-23       Impact factor: 29.983

Review 4.  How to assess sympathetic activity in humans.

Authors:  G Grassi; M Esler
Journal:  J Hypertens       Date:  1999-06       Impact factor: 4.844

5.  Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients.

Authors:  J Blacher; R Asmar; S Djane; G M London; M E Safar
Journal:  Hypertension       Date:  1999-05       Impact factor: 10.190

6.  Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome.

Authors:  G Grassi; R Dell'Oro; F Quarti-Trevano; F Scopelliti; G Seravalle; F Paleari; P L Gamba; G Mancia
Journal:  Diabetologia       Date:  2005-06-03       Impact factor: 10.122

7.  Sympathoexcitation by central ANG II: roles for AT1 receptor upregulation and NAD(P)H oxidase in RVLM.

Authors:  Lie Gao; Wei Wang; Yu-Long Li; Harold D Schultz; Dongmei Liu; Kurtis G Cornish; Irving H Zucker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-01-06       Impact factor: 4.733

8.  Rilmenidine prevents blood pressure increase in rats with compromised nitric oxide production.

Authors:  Mária Gerová; Jozef Török; Ol'ga Pecháòová; Jana Matusková
Journal:  Acta Pharmacol Sin       Date:  2004-12       Impact factor: 6.150

9.  Sympathetic tone restrains arterial distensibility of healthy and atherosclerotic subjects.

Authors:  M Failla; A Grappiolo; G Emanuelli; G Vitale; N Fraschini; M Bigoni; N Grieco; M Denti; C Giannattasio; G Mancia
Journal:  J Hypertens       Date:  1999-08       Impact factor: 4.844

Review 10.  Sympathetic and baroreflex function in hypertension: implications for current and new drugs.

Authors:  Guido Grassi
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

View more
  76 in total

Review 1.  Sympathetic nervous system as a target for aging and obesity-related cardiovascular diseases.

Authors:  Priya Balasubramanian; Delton Hall; Madhan Subramanian
Journal:  Geroscience       Date:  2018-12-05       Impact factor: 7.713

2.  (In)activity-dependent alterations in resting and reflex control of splanchnic sympathetic nerve activity.

Authors:  Nicholas A Mischel; Patrick J Mueller
Journal:  J Appl Physiol (1985)       Date:  2011-10-06

3.  Relaxin increases sympathetic nerve activity and activates spinally projecting neurons in the paraventricular nucleus of nonpregnant, but not pregnant, rats.

Authors:  K Max Coldren; Randall Brown; Eileen M Hasser; Cheryl M Heesch
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-09-23       Impact factor: 3.619

4.  The relationship of a family history for hypertension, myocardial infarction, or stroke with cardiovascular physiology in young women.

Authors:  Carole A McBride; Sarah A Hale; Meenakumari Subramanian; Gary J Badger; Ira M Bernstein
Journal:  Reprod Sci       Date:  2013-09-10       Impact factor: 3.060

5.  Increased muscle sympathetic nerve activity acutely alters conduit artery shear rate patterns.

Authors:  Jaume Padilla; Colin N Young; Grant H Simmons; Shekhar H Deo; Sean C Newcomer; John P Sullivan; M Harold Laughlin; Paul J Fadel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-02-12       Impact factor: 4.733

Review 6.  The sympathetic nervous system and heart failure.

Authors:  David Y Zhang; Allen S Anderson
Journal:  Cardiol Clin       Date:  2014-02       Impact factor: 2.213

7.  High-fat food, sympathetic nerve activity, and hypertension: danger soon after the first bite?

Authors:  Virginia L Brooks; John W Osborn
Journal:  Hypertension       Date:  2012-10-22       Impact factor: 10.190

Review 8.  Neural Control of Non-vasomotor Organs in Hypertension.

Authors:  Chansol Hurr; Colin N Young
Journal:  Curr Hypertens Rep       Date:  2016-04       Impact factor: 5.369

Review 9.  Prognostic significance and therapeutic option of heart rate variability in chronic kidney disease.

Authors:  Jing Zhang; Ningning Wang
Journal:  Int Urol Nephrol       Date:  2013-03-29       Impact factor: 2.370

Review 10.  Blood pressure regulation XI: overview and future research directions.

Authors:  Peter B Raven; Mark W Chapleau
Journal:  Eur J Appl Physiol       Date:  2014-01-28       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.